Nrc Health's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nrc Health's ROA in the third quarter of 2026?
Nrc Health achieved a return on average assets (ROA) of 4.71 % in its third quarter of 2026, which is below Nrc Health's average return on assets, which stands at 19.95%.

ROA has improved compared to 4.32% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 163 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 849 to 944.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	3.21 %	-3.37 %	-0.38 %	1.9 %	2.34 %
Y / Y Net Income Change	14.12 %	-	-44.32 %	-72.61 %	-27.53 %
Net Income (TTM) in million	6	6	9	12	16
Return On Assets (TTM)	4.71 %	4.32 %	6.63 %	8.5 %	12.05 %
NRC's Total Ranking	# 944	# 849	# 492	# 411	# 259
Total Assets (TTM) in million	139	136	135	135	135
Seq. Total Assets Change	2.25 %	1.18 %	-0.24 %	0 %	-4.27 %
Seq. Net Income Change	-	-	79.3 %	-56.4 %	-

NRC's 5 Years Annual ROA >> Back to NRC Management Effectiveness >> Compare NRC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 11
Sector	# 164
Overall	# 1297

Return On Assets Statistics
High	Average	Low
32.81 %	19.95 %	4.31 %
(Mar 31 2020)		(Jun 30 2026)

Financial Statements
Nrc Health's Assets	$ 139 million	NRC's Balance sheet
Nrc Health's Income	$ 5 million	Quarterly NRC's Income Statement
NRC's Income by Division		See NRC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	1.9 %	8.11 %	-5.95 %	-16.81 %	19.92 %
Total Assets in million	135	132	122	130	157
Y / Y Net Income Change	-53.19 %	-19.98 %	-2.61 %	-15.12 %	0.55 %
Net Income in million	12	25	31	32	37
Annual Return On Assets	8.6 %	18.72 %	25.3 %	24.43 %	23.94 %

NRC's 5 Years Annual ROA >> Back to NRC Management Effectiveness >> Compare NRC ROA to its Competitors

Comment on NRC's ROA in the fiscal year ending 2025

In the fiscal year 2025 Nrc Health's ROA decreased compared to previous year to 8.6 %, due to deterioration of net income -53.19 % to $11.60 million, from $24.78 million a year ago, as NRC's assets were $134.88 million.

More Return On Assets Ratios
NRC's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NRC's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NRC's Competitors
Subscribers only: Roa for Nrc Health's Suppliers
Subscribers only: Return On Assets for NRC's Customers

You may also want to know
NRC's Roi	NRC's Inventory Turnover Ratio	NRC's Growth Rates	NRC's Dividend Comparisons
	NRC's Profitability Ratios	NRC's Asset Turnover Ratio	NRC's Dividend Growth
NRC's Roe	NRC's Valuation Ratios	NRC's Financial Strength Ratios	NRC's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %
Pediatrix Medical Group Inc	6.99 %
Quest Diagnostics Inc	6.96 %
Davita Inc	6.65 %
Brightspring Health Services Inc	6.60 %

Date modified: 2026-11-06T12:52:49+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.